A coagulation analyzer may require only a small aspiration volume for one PT, APTT, fibrinogen, TT, D-Dimer, FDP, or antithrombin result. Yet the volume that must be placed on the analyzer is always larger than the analytical aspiration itself. Container geometry, probe reach, repeat testing, reflex rules, and evaporation all add to the practical requirement. When laboratories treat the assay volume as the total sample requirement, they create avoidable insufficient-sample flags, manual transfers, and recollection requests.
Sample sufficiency is therefore a workflow calculation, not a single number from an instrument brochure. A robust policy connects collection, plasma preparation, sample cup selection, analyzer settings, and the laboratory’s test menu. It also distinguishes the volume needed for one aspiration from the volume needed to complete the requested episode of testing.
Separate aspiration volume from dead volume
Aspiration volume is the amount the analyzer draws for a test. Dead volume is the plasma that remains inaccessible because the probe cannot safely reach the container bottom or because the liquid must cover a minimum area for reliable aspiration. The combined minimum depends on the tube or cup shape. A narrow conical insert may provide a lower dead volume than a wide flat-bottom cup, even when both containers have the same nominal capacity.
Instrument specifications should be checked for each approved container type. Laboratories should not assume that values for a primary citrate tube also apply to a secondary cup. Probe height detection, cap piercing, sample-level sensing, and clot detection can change the practical limit. Local verification with the actual racks, cups, and software configuration is more useful than relying only on a theoretical value.
Calculate the complete testing pathway
The starting calculation should include every planned aspiration. For a request containing PT and APTT, add both analytical volumes, the container dead volume, and an allowance for a repeat if required by policy. If an abnormal screening result can trigger fibrinogen, TT, a mixing study, or another reflex test, the laboratory should decide whether to reserve volume for that pathway.
Calibrators and controls need similar planning. A vial may support a stated number of tests under ideal conditions, but the usable number can be lower after dead volume, replicate calibration points, reruns, and onboard evaporation are considered. This difference matters for inventory forecasts and kit configuration, especially in low-volume laboratories where small vials may remain open for longer periods.
Account for plasma yield after centrifugation
The volume collected in a citrate tube is not equal to the final available plasma volume. Cellular components occupy part of the tube, and adequate separation must be maintained when removing plasma. A high hematocrit can reduce plasma yield further and may also require citrate adjustment under the laboratory’s procedure. Underfilled tubes are primarily a blood-to-anticoagulant ratio problem and should not be accepted merely because the remaining plasma appears sufficient.
After centrifugation, staff should avoid disturbing the cell layer when transferring plasma. Taking the last possible microliters can increase cellular or platelet contamination. If platelet-poor plasma is required for a specialized workflow, the additional centrifugation and transfer steps may reduce available volume again. The volume policy should reflect the required plasma quality, not only the analyzer’s ability to aspirate.
Choose the sample cup deliberately
Secondary cups are useful when primary tubes contain too little plasma for direct aspiration, when samples have been aliquoted, or when analyzer racks require a specific format. Cup choice should be standardized. Approved cups need compatible dimensions, stable rack placement, suitable material, and a geometry that supports the expected minimum volume.
Transferring plasma into a cup does not automatically solve a low-volume problem. Liquid can remain in the transfer pipette or on the original tube wall, and an overly wide cup can leave more inaccessible volume than the primary tube. Excessively small cups may tilt, fit the rack poorly, or create identification risks. Laboratories should test their chosen cups across the intended range and document the minimum loading volume that consistently produces valid aspiration.
Protect identification during manual transfers
Every transfer adds an identification step. The cup should be linked unambiguously to the original specimen using the laboratory’s barcode or accession process. Handwritten shorthand, open cups arranged only by position, and batch transfers without immediate labeling create risk that is more serious than the volume problem being solved.
The procedure should specify who performs the transfer, how the source and destination are matched, whether a witness or electronic check is required, and how the primary tube is retained. If several aliquots are made, each should have a defined purpose and traceable identity.
Control evaporation and onboard time
Small volumes have a high surface-area-to-volume ratio and are more vulnerable to evaporation. An open cup left on an analyzer can lose enough water to alter concentration or fall below the aspiration threshold, particularly in warm or dry environments. The analyzer may also mix, sample, or move cups in ways that increase exposure.
Define a maximum onboard time for low-volume samples and use caps or covers where the validated workflow permits. Avoid preparing secondary cups much earlier than needed. When a delayed reflex test is likely, retaining a properly stored aliquot may be preferable to leaving all remaining plasma open on the analyzer.
Set rules for insufficient samples
Staff need a consistent decision path when volume is limited. The policy may prioritize the originally requested tests, reserve material for confirmation, or require consultation before changing the test sequence. It should also define when dilution is prohibited, since dilution can invalidate many coagulation assays unless it is an explicit part of the method.
An insufficient-sample result should distinguish between collection failure, low plasma yield, and analyzer dead-volume limitations where possible. Clear comments help clinicians understand why a result is unavailable and whether recollection is needed. Tracking these events by ward, tube type, and test combination can reveal training or workflow problems.
Verify volume claims during implementation
When adopting a new analyzer, application, or cup, challenge the minimum-volume claim under routine conditions. Test multiple cups near the proposed threshold, include repeated aspirations, and observe level-sensing and clot-detection behavior. Confirm that results remain consistent and that probes do not contact container bottoms. Recheck the workflow after software, rack, or consumable changes.
For distributors and manufacturers, useful application support includes container-specific dead-volume data, approved cup references, aspiration volumes by assay, and examples of multi-test calculations. Kit planning should reflect real usable volume rather than nominal fill alone.
Careful sample-volume management protects both analytical quality and patient workflow. By calculating the full testing pathway, using verified containers, controlling transfers and evaporation, and defining low-volume decisions in advance, laboratories can reduce preventable reruns and make better use of every acceptable citrate specimen.